Sponsor Pipeline

Anwaar Saeed Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06698250 Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular… Hepatocellular Carcinoma Recruiting
Phase 1/2
NCT03539822 Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With… Gastric Cancer Recruiting
Phase 1
NCT06896188 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced… Pancreatic Adenocarcinoma Recruiting
Disease Areas
Liver Cancer (2) Colorectal Cancer (1) Gastric Cancer (1)
Get alerts when Anwaar Saeed's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free